Results 181 to 190 of about 757,022 (291)

Antiviral influenza treatments and hemorrhage‐related adverse events in the United States Food and Drug Administration Adverse Event Reporting System (FAERS) database [PDF]

Jyotirmoy Sarker, Emir Carkovic, Karolina Ptaszek, Todd A. Lee   +3 more
openalex   +1 more source

Opioid and Benzodiazepine Coprescribing in the United States Before and After US Food and Drug Administration Boxed Warning [PDF]

, 2019
Victoria Zhang, Mark Olfson, Marissa King   +2 more
openalex   +1 more source

Comparison of Good Clinical Practice Inspection Processes for Marketing Applications between the United States Food and Drug Administration and the European Medicines Agency [PDF]

, 2022
Kassa Ayalew, Yang‐Min Ning, Michelle J. Foringer, Susan Leibenhaut, Jenn W. Sellers, Bei Yu, Phillip D. Kronstein, Agata Higgerson, Camelia Mihaescu, Miguel Rodriguez, LaKisha Williams, Ni A. Khin   +11 more
openalex   +1 more source

Bio‐Friendly Artificial Muscles Based on Carbon Nanotube Yarns and Eutectogel Derivatives

Advanced Functional Materials, EarlyView.
Solid‐state artificial muscles based on coiled commercial carbon nanotube yarns coated with eutectogel derivatives exhibit unipolar actuation through selective ion intercalation. Combining polyanionic and polycationic gels enables enhanced contractile stroke and high energy density.
Gabriela Ananieva, Cédric Vancaeyzeele, Giao T.M. Nguyen, Daniel Aguilera‐Bulla, Mathieu Pinault, Frédéric Vidal, Cédric Plesse   +6 more
wiley   +1 more source

Evaluation of the EVO/EVO+ Sphere and Toric Visian ICL: Six Month Results from the United States Food and Drug Administration Clinical Trial. [PDF]

Clin Ophthalmol, 2022
Packer M.
europepmc   +1 more source

Has the Demand for Fats and Meats in the United States been Affected by the Health Claim on Risk of Coronary Heart Disease Issued by the Food and Drug Administration?

, 2022
Stavroula Malla, K. K. Klein, Taryn Presseau   +2 more
openalex   +1 more source

Real-world study of antifibrotic drugs-related adverse events based on the United States Food and Drug Administration Adverse Event Reporting System and VigiAccess databases [PDF]

, 2023
M. He, Jian Zhou, Taoran Yang, Xuehan Li, Rurong Wang   +4 more
openalex   +1 more source

Programmable DNA‐Peptide Hybrid Nanostructures for Potent Neutralization of Multiple Influenza a Virus Subtypes

Advanced Functional Materials, EarlyView.
A multivalent antiviral platform based on honeycomb‐shaped DNA nanostructures (HC–Urumin) is developed to enhance the potency and breadth of the host defense peptide Urumin. Through spatially patterned trimeric presentation, HC–Urumin disrupts influenza A virus entry, improves cell viability, and reduces disease severity in vivo‐offering a modular and ...
Saurabh Umrao, Abhisek Dwivedy, Payton L. Haak, Dhanush Gandavadi, Laurie A. Rund, Chi Chen, Vineetha Mareddy, Lifeng Zhou, Jinwei Duan, Ying Fang, Andrew J. Steelman, Xing Wang   +11 more
wiley   +1 more source

Upconversion Nanoparticles Embedded Photonic Contact Lens for Transepithelial Corneal Crosslinking Using Hyaluronate – Riboflavin Conjugate

Advanced Functional Materials, EarlyView.
A minimally invasive, transepithelial corneal cross‐linking (TE‐CXL) approach is presented using upconversion nanoparticles (UCNPs)‐loaded contact lenses (UCLs), after topical delivery of hyaluronate–riboflavin conjugates. The NIR‐to‐UV/blue light conversion by UCNPs in a UCL can activate riboflavin for TE‐CXL, resulting in the biomechanical strength ...
Gibum Lee, Inhoo Choi, Anara Molkenova, Yengwoo Son, Seungmin Yang, Mina Kwon, Tae‐Im Kim, Ki Su Kim, Sei Kwang Hahn   +8 more
wiley   +1 more source

Adverse events related to total ankle replacement devices: an analysis of reports to the United States Food and Drug Administration. [PDF]

Int Orthop, 2021
Mahmoud K, Metikala S, O'Connor KM, Farber DC.   +3 more
europepmc   +1 more source